Overviews of Procedures and Diagnostic Tests for Advanced Practice Providers (On-Demand)
SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 90 Minutes
Overview
This educational program provides a review of key diagnostic tests and procedures that advanced practice providers encounter in patient care, including description, indications, and interpretation of results, along with clinical practice applications.
Learning Objectives
- Describe the procedural overview, clinical indications, and interpretation of bone marrow biopsy results
- Discuss the procedural overview, clinical indications, and interpretation of cerebrospinal fluid analysis from lumbar punctures
- Recognize the differences between various radiological imaging modalities, including identifying appropriate clinical scenarios for each and the basic principles of interpreting these images
- Identify when to order molecular tests, implications of these test results, and integrate them into patients’ overall diagnostic and treatment plans in selected cancers
Target Audience:
This activity is intended for oncology nurse practitioners, physician assistants, nurses, and other healthcare providers involved in the care of cancer patients.
This Evenings in Onboarding on-demand program is supported by independent medical educational grants from Merck Sharp & Dohme LLC and Regeneron Pharmaceuticals, Inc.
Presented By
Faculty
Laura Zitella, MS, RN, ACNP-BC, AOCN
Laura J. Zitella is a hematology nurse practitioner at UCSF Health in the Hematology, Blood & Marrow Transplant, and Cellular Therapy (HBC) Program and has a volunteer faculty appointment as Associate Clinical Professor in the Department of Physiological Nursing at the University of California San Francisco. She earned her Master of Science from the University of Illinois in Chicago.
Laura holds certifications as an Acute Care Nurse Practitioner and an Advanced Oncology Certified Nurse. With more than 25 years of experience in oncology practice, Ms. Zitella is recognized as a national nurse practitioner leader. Her clinical expertise includes patients with hematologic malignancies receiving chemotherapy, immunotherapy, targeted therapy, investigational agents, hematopoietic cell transplantation, and supportive care. She is a prominent educator who has delivered hundreds of educational presentations to national and international audiences and authored numerous peer-reviewed publications, web courses, videos, and book chapters.
Disclosures:
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous.
All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.
Laura Zitella, MS, RN, ACNP-BC, AOCN discloses the following: Advisory Boards: BeiGene, AbbVie - These relationships have ended
Available Credit
- 1.50 AMA PRA Category 1 Credit™Horizon CME designates this Enduring activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.50 ANCCThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.50 credit.
- 0.25 PharmacologyThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 0.25 credit.
Price
Required Hardware/software
Access to internet required
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above